COST-EFFECTIVENESS ANALYSIS OF SACUBITRIL/VALSARTAN IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR ELIGIBLE PATIENTS

被引:0
|
作者
Kaddoura, R. [1 ]
Abushanab, D. [2 ]
Arabi, A. R. [3 ]
Al-Badriyeh, D. [4 ]
机构
[1] Hamad Med Corp, Heart Hosp, Pharm Dept, Doha, Qatar
[2] Hamad Med Corp, Doha, Qatar
[3] Hamad Med Corp, Heart Hosp, Cardiol Dept, Doha, Qatar
[4] Qatar Univ, Qatar Univ Hlth, Coll Pharm, Doha, Qatar
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE432
引用
收藏
页码:S419 / S419
页数:1
相关论文
共 50 条
  • [11] COST-EFFECTIVENESS OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN PATIENTS WITH RISK FACTORS FOR SUDDEN DEATH IN ARGENTINA
    Alcaraz, A.
    Gonzalez Zuelgaray, J.
    Augustovski, F.
    VALUE IN HEALTH, 2011, 14 (07) : A535 - A535
  • [12] Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator the - Canadian Implantable Defibrillator Study
    Sheldon, R
    O'Brien, BJ
    Blackhouse, G
    Goeree, R
    Mitchell, B
    Klein, G
    Roberts, RS
    Gent, M
    Connolly, SJ
    CIRCULATION, 2001, 104 (14) : 1622 - 1626
  • [13] The effect of clinical risk stratification on the cost-effectiveness of the implantable cardioverter-defibrillator: The Canadian implantable defibrillator study
    Sheldon, RS
    O'Brien, B
    Blackhouse, G
    Goeree, R
    Mitchell, B
    Klein, G
    Roberts, R
    Gent, M
    Connolly, SJ
    CIRCULATION, 2001, 104 (17) : 345 - 345
  • [14] Cost-Effectiveness of the Implantable Cardioverter Defibrillator in the Elderly
    Sanders, Gillian O.
    Kong, Melissa
    Al-Khatib, Sana M.
    Peterson, Eric D.
    CIRCULATION, 2008, 118 (18) : S1118 - S1118
  • [15] AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR - COST-EFFECTIVENESS
    HAUER, RNW
    WEVER, EFD
    CRIJNS, HJGM
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1993, 16 (03): : 559 - 563
  • [16] Cost-effectiveness of implantable cardioverter defibrillator therapy
    Morgan, JM
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2002, 13 (01) : S114 - S117
  • [17] Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation
    Healy, Christopher A.
    Carrillo, Roger G.
    HEART RHYTHM, 2015, 12 (07) : 1565 - 1573
  • [18] COST-EFFECTIVENESS OF THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR - A PRELIMINARY-ANALYSIS
    OBRIEN, BJ
    BUXTON, MJ
    RUSHBY, JA
    BRITISH HEART JOURNAL, 1992, 68 (02): : 241 - 245
  • [19] COST-EFFECTIVENESS OF WEARABLE CARDIOVERTER-DEFIBRILLATOR IN CHINA: A DECISION ANALYSIS
    Jiang, X.
    Ming, W. K.
    You, J.
    VALUE IN HEALTH, 2019, 22 : S547 - S547
  • [20] RELATIONSHIP OF COST-EFFECTIVENESS OF THE TRANSTHORACIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR TO PATIENT CATEGORY AND CLINICAL STRATEGY
    GUERRERO, P
    HOGAN, A
    GARDINER, J
    MELLITS, D
    BAUMGARDNER, R
    ROVNER, D
    HOLMESROVNER, M
    MCLANE, A
    LEVINE, J
    GRIFFITH, L
    KUPERSMITH, J
    CIRCULATION, 1993, 88 (04) : 144 - 144